Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-21-031092

Chief Financial Officer bought 10,125 shares at $8.00 ($81,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Canepa John J Chief Financial Officer 2021-07-29 Purchase +10,125 $8.00 $81,000 10,125 D: show line 1 in the form
Open-market purchases · 10,125 sh · avg $8.00 · $81,000
Loading xslF345X03/doc4.xml…